These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18952441)

  • 1. Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry.
    Lam SN; Acharya P; Wyatt R; Kwong PD; Bewley CA
    Bioorg Med Chem; 2008 Dec; 16(23):10113-20. PubMed ID: 18952441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.
    Cormier EG; Persuh M; Thompson DA; Lin SW; Sakmar TP; Olson WC; Dragic T
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5762-7. PubMed ID: 10823934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
    Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
    EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120.
    Brower ET; Schön A; Klein JC; Freire E
    Biochemistry; 2009 Feb; 48(4):779-85. PubMed ID: 19170639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4.
    Huang CC; Lam SN; Acharya P; Tang M; Xiang SH; Hussan SS; Stanfield RL; Robinson J; Sodroski J; Wilson IA; Wyatt R; Bewley CA; Kwong PD
    Science; 2007 Sep; 317(5846):1930-4. PubMed ID: 17901336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The conformation and orientation of a 27-residue CCR5 peptide in a ternary complex with HIV-1 gp120 and a CD4-mimic peptide.
    Schnur E; Noah E; Ayzenshtat I; Sargsyan H; Inui T; Ding FX; Arshava B; Sagi Y; Kessler N; Levy R; Scherf T; Naider F; Anglister J
    J Mol Biol; 2011 Jul; 410(5):778-97. PubMed ID: 21763489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry.
    Farzan M; Vasilieva N; Schnitzler CE; Chung S; Robinson J; Gerard NP; Gerard C; Choe H; Sodroski J
    J Biol Chem; 2000 Oct; 275(43):33516-21. PubMed ID: 10938094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
    Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
    J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.
    Choe H; Li W; Wright PL; Vasilieva N; Venturi M; Huang CC; Grundner C; Dorfman T; Zwick MB; Wang L; Rosenberg ES; Kwong PD; Burton DR; Robinson JE; Sodroski JG; Farzan M
    Cell; 2003 Jul; 114(2):161-70. PubMed ID: 12887918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible and efficient activation of HIV-1 cell entry by a tyrosine-sulfated peptide dissects endocytic entry and inhibitor mechanisms.
    Platt EJ; Gomes MM; Kabat D
    J Virol; 2014 Apr; 88(8):4304-18. PubMed ID: 24478426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection.
    Dorfman T; Moore MJ; Guth AC; Choe H; Farzan M
    J Biol Chem; 2006 Sep; 281(39):28529-35. PubMed ID: 16849323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the determinants of the CCR5 amino-terminal sulfopeptide interaction with soluble human immunodeficiency virus type 1 gp120-CD4 complexes.
    Cormier EG; Tran DN; Yukhayeva L; Olson WC; Dragic T
    J Virol; 2001 Jun; 75(12):5541-9. PubMed ID: 11356961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.
    Bashir T; Patgaonkar M; Kumar SC; Pasi A; Reddy KV
    PLoS One; 2015; 10(4):e0124839. PubMed ID: 25915507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage.
    Dervillez X; Klaukien V; Dürr R; Koch J; Kreutz A; Haarmann T; Stoll M; Lee D; Carlomagno T; Schnierle B; Möbius K; Königs C; Griesinger C; Dietrich U
    J Virol; 2010 Oct; 84(19):10131-8. PubMed ID: 20660187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based identification and neutralization mechanism of tyrosine sulfate mimetics that inhibit HIV-1 entry.
    Acharya P; Dogo-Isonagie C; LaLonde JM; Lam SN; Leslie GJ; Louder MK; Frye LL; Debnath AK; Greenwood JR; Luongo TS; Martin L; Watts KS; Hoxie JA; Mascola JR; Bewley CA; Kwong PD
    ACS Chem Biol; 2011 Oct; 6(10):1069-77. PubMed ID: 21793507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a V3-containing HIV-1 gp120 core.
    Huang CC; Tang M; Zhang MY; Majeed S; Montabana E; Stanfield RL; Dimitrov DS; Korber B; Sodroski J; Wilson IA; Wyatt R; Kwong PD
    Science; 2005 Nov; 310(5750):1025-8. PubMed ID: 16284180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.
    Zhang W; Godillot AP; Wyatt R; Sodroski J; Chaiken I
    Biochemistry; 2001 Feb; 40(6):1662-70. PubMed ID: 11327825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple binding modes of an N-terminal CCR5-peptide in complex with HIV-1 gp120.
    Moseri A; Akabayov SR; Cohen LS; Naider F; Anglister J
    FEBS J; 2022 Jun; 289(11):3132-3147. PubMed ID: 34921512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.